UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (825) 825
Book Chapter (11) 11
Conference Proceeding (7) 7
Publication (3) 3
Web Resource (3) 3
Book / eBook (2) 2
Patent (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (309) 309
life sciences & biomedicine (304) 304
humans (268) 268
oncology (160) 160
hematology (153) 153
multiple myeloma - drug therapy (151) 151
multiple myeloma (145) 145
female (110) 110
male (109) 109
middle aged (105) 105
aged (95) 95
antineoplastic combined chemotherapy protocols - therapeutic use (91) 91
adult (87) 87
bortezomib (84) 84
abridged index medicus (73) 73
treatment outcome (71) 71
antineoplastic agents - therapeutic use (61) 61
multiple myeloma - pathology (57) 57
multiple myeloma - therapy (52) 52
recurrence (48) 48
aged, 80 and over (45) 45
cancer (45) 45
hematology, oncology and palliative medicine (45) 45
multiple myeloma - mortality (45) 45
care and treatment (43) 43
thalidomide - analogs & derivatives (39) 39
antineoplastic combined chemotherapy protocols - adverse effects (38) 38
dexamethasone - administration & dosage (38) 38
animals (35) 35
myeloma (33) 33
prognosis (33) 33
transplantation (33) 33
dexamethasone (30) 30
patients (30) 30
proteasome inhibitors (29) 29
cell line, tumor (28) 28
disease-free survival (28) 28
drug resistance, neoplasm (28) 28
stem cell transplantation (28) 28
cell biology (26) 26
drug therapy (26) 26
multiple myeloma - diagnosis (26) 26
multiple myeloma - genetics (26) 26
analysis (25) 25
thalidomide - administration & dosage (25) 25
antineoplastic agents - adverse effects (24) 24
boronic acids - administration & dosage (24) 24
boronic acids - therapeutic use (24) 24
hemic and lymphatic diseases (24) 24
pyrazines - administration & dosage (24) 24
pyrazines - therapeutic use (24) 24
multiple myeloma - metabolism (23) 23
survival analysis (23) 23
clinical trials (22) 22
clinical trials as topic (22) 22
transplantation, autologous (22) 22
mice (21) 21
research (20) 20
stem cells (20) 20
thalidomide - therapeutic use (20) 20
boronic acids - adverse effects (19) 19
clinical trials and observations (19) 19
drug administration schedule (19) 19
medical colleges (19) 19
monoclonal antibodies (19) 19
neoplasm recurrence, local - drug therapy (19) 19
patient outcomes (19) 19
pyrazines - adverse effects (19) 19
antibodies, monoclonal - therapeutic use (17) 17
antineoplastic agents - administration & dosage (17) 17
antineoplastic agents - pharmacology (17) 17
biochemistry & molecular biology (17) 17
chemotherapy (17) 17
immunology (17) 17
survival rate (17) 17
diagnosis (16) 16
dose-response relationship, drug (16) 16
follow-up studies (16) 16
health aspects (16) 16
bone marrow (15) 15
dexamethasone - therapeutic use (15) 15
immune system diseases (15) 15
proteins (15) 15
transplantation, homologous (15) 15
apoptosis (14) 14
carfilzomib (14) 14
cohort studies (14) 14
disease progression (14) 14
hematopoietic stem cell transplantation (14) 14
hematopoietic stem cell transplantation - methods (14) 14
neoplasm staging (14) 14
retrospective studies (14) 14
risk factors (14) 14
survival (14) 14
thalidomide (14) 14
apoptosis - drug effects (13) 13
immunologic factors - therapeutic use (13) 13
immunomodulation (13) 13
kaplan-meier estimate (13) 13
lymphoid neoplasia (13) 13
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 2009, Volume 114, Issue 3, pp. 496 - 497
The present and future for patients with myeloma has never looked better. Yet for high-risk patients, much work remains to be done. 
Life Sciences & Biomedicine | Hematology | Science & Technology
Journal Article
Journal Article
Journal Article